BAKER BROS. ADVISORS LP Diversified Active

Location: New York, NY

CIK: 0001263508 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value: $10.82B (84.3% shares, 15.7% debt)

Holdings (133)

INCY Incyte Corporation 19.9%
Value $2.149B Shares 19,474,969 Est. Cost $43.21 Unrealized +159.5%
Seattle Genetics, Inc. 12.8%
Value $1.389B Shares 36,029,746 Est. Cost $34.28 Unrealized
Alexion Pharmaceuticals, Inc. 9.5%
Value $1.023B Shares 6,542,599 Est. Cost $180.77 Unrealized
ABBV AbbVie Inc. 7.2%
Value $782M Shares 14,373,538 Est. Cost $42.33 Unrealized +0.4%
ACAD ACADIA Pharmaceuticals Inc. 6.3%
Value $677M Shares 20,481,442 Est. Cost $14.07 Unrealized +195.7%
Incyte Corporation Notes 1.25% 11/15/2020 144A 5.5%
Value $599M Shares 274,500,000 Est. Cost $1.21 Unrealized
Incyte Corporation Notes 0.375% 11/15/2018 144A 5.2%
Value $560M Shares 259,000,000 Est. Cost $1.20 Unrealized
Anacor Pharmaceuticals, Inc. 4.5%
Value $487M Shares 4,135,412 Est. Cost $31.19 Unrealized
BMRN BioMarin Pharmaceutical Inc. 4.0%
Value $429M Shares 4,076,353 Est. Cost $75.89 Unrealized +76.0%
Genomic Health Inc. 2.7%
Value $289M Shares 13,658,328 Est. Cost $31.71 Unrealized
Clovis Oncology Inc. 2.5% 9/15/2021 2.0%
Value $215M Shares 129,300,000 Est. Cost $1.67 Unrealized
DBV Technologies S.A. 1.8%
Value $194M Shares 5,462,019 Est. Cost $32.87 Unrealized
BCRX BioCryst Pharmaceuticals, Inc. 1.5%
Value $161M Shares 14,110,179 Est. Cost $7.53 Unrealized +77.2%
Dyax Corp. 1.3%
Value $144M Shares 7,561,480 Est. Cost $13.14 Unrealized
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 1.1%
Value $116M Shares 22,379,000 Est. Cost $2.76 Unrealized
Mirati Therapeutics, Inc. 0.9%
Value $102M Shares 2,955,074 Est. Cost $18.37 Unrealized
Aquinox Pharmaceuticals, Inc. 0.9%
Value $94.94M Shares 6,747,332 Est. Cost $13.83 Unrealized
Gilead, Inc. 1.625% 5/1/16 0.8%
Value $90.33M Shares 20,944,000 Est. Cost $2.26 Unrealized
HRTX Heron Therapeutics, Inc. 0.7%
Value $70.95M Shares 2,907,784 Est. Cost $13.64 Unrealized +144.2%
CERS Cerus Corporation 0.6%
Value $61.53M Shares 13,553,275 Est. Cost $4.68 Unrealized +10.5%
Bellicum Pharmaceuticals, Inc. 0.6%
Value $60.89M Shares 4,190,594 Est. Cost $23.04 Unrealized
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 0.5%
Value $54.12M Shares 59,583,000 Est. Cost $1.04 Unrealized
Spark Therapeutics, Inc. 0.5%
Value $52.68M Shares 1,262,382 Est. Cost $77.50 Unrealized
Invitae Corporation 0.4%
Value $47.33M Shares 6,554,967 Est. Cost $16.76 Unrealized
Versartis, Inc. 0.3%
Value $37.38M Shares 3,241,783 Est. Cost $22.68 Unrealized
ImmunoGen, Inc. 0.3%
Value $34.06M Shares 3,548,040 Est. Cost $11.20 Unrealized
NBIX Neurocrine Biosciences, Inc. 0.3%
Value $29.87M Shares 750,739 Est. Cost $25.36 Unrealized +90.6%
INSM Insmed, Inc. 0.3%
Value $29.41M Shares 1,583,490 Est. Cost $14.99 Unrealized +66.6%
Acorda Therapeutics, Inc. 0.3%
Value $29.08M Shares 1,096,876 Est. Cost $34.19 Unrealized
Medivation, Inc. 0.3%
Value $28.04M Shares 659,752 Est. Cost $42.50 Unrealized
HALO Halozyme Therapeutics, Inc. 0.2%
Value $25.93M Shares 1,931,057 Est. Cost $6.50 Unrealized +209.0%
Progenics Pharmaceuticals, Inc. 0.2%
Value $24.89M Shares 4,350,808 Est. Cost $4.44 Unrealized
GILD Gilead Sciences, Inc. 0.2%
Value $24.55M Shares 249,995 Est. Cost $36.21 Unrealized +114.0%
Intra-Cellular Therapies, Inc. 0.2%
Value $24.39M Shares 609,166 Est. Cost $37.28 Unrealized
Zogenix, Inc. 0.2%
Value $24.28M Shares 1,798,365 Est. Cost $13.50 Unrealized
Exelisis, Inc. Notes 4.25% 8/15/2019 0.2%
Value $23.99M Shares 20,000,000 Est. Cost $1.20 Unrealized
aTyr Pharma Inc. 0.2%
Value $23.96M Shares 2,335,125 Est. Cost $18.52 Unrealized
Idera Pharmaceuticals, Inc. 0.2%
Value $23.37M Shares 6,976,162 Est. Cost $3.05 Unrealized
XenoPort, Inc. 0.2%
Value $22.59M Shares 6,508,622 Est. Cost $5.27 Unrealized
CPRX Catalyst Pharmaceuticals, Inc. 0.2%
Value $22.01M Shares 7,335,692 Est. Cost $2.58 Unrealized +67.2%
SGMO Sangamo BioSciences, Inc. 0.2%
Value $21.18M Shares 3,755,876 Est. Cost $12.49 Unrealized -34.0%
TGTX TG Therapeutics, Inc. 0.2%
Value $20.2M Shares 2,003,991 Est. Cost $4.61 Unrealized +223.5%
Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 0.2%
Value $19.87M Shares 26,517,000 Est. Cost $0.75 Unrealized
Array BioPharma Inc. 0.2%
Value $19.66M Shares 4,310,666 Est. Cost $6.65 Unrealized
Clovis Oncology, Inc. 0.2%
Value $18.63M Shares 202,630 Est. Cost $56.00 Unrealized
Alder Biopharmaceuticals Inc. 0.2%
Value $16.82M Shares 513,439 Est. Cost $27.68 Unrealized
Derma Sciences, Inc. 0.2%
Value $16.29M Shares 3,457,841 Est. Cost $12.84 Unrealized
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 0.1%
Value $15.9M Shares 12,228,000 Est. Cost $1.06 Unrealized
Novavax, Inc. 0.1%
Value $15.52M Shares 2,195,687 Est. Cost $5.28 Unrealized
GLPG Galapagos NV ADR 0.1%
Value $15.03M Shares 369,276 Est. Cost $51.50 Unrealized
Foamix Pharmaceuticals Ltd. 0.1%
Value $15M Shares 2,046,967 Est. Cost $7.46 Unrealized
Repros Therapeutics Inc. 0.1%
Value $14.53M Shares 1,955,944 Est. Cost $18.45 Unrealized
PRQR ProQR Therapeutics N.V. 0.1%
Value $14.4M Shares 988,299 Est. Cost $17.70 Unrealized -5.4%
Achillion Pharmaceuticals, Inc. 0.1%
Value $13.82M Shares 2,000,000 Est. Cost $8.32 Unrealized
Zafgen, Inc. 0.1%
Value $12.47M Shares 390,346 Est. Cost $35.13 Unrealized
bluebird bio, Inc. 0.1%
Value $12.07M Shares 141,105 Est. Cost $29.38 Unrealized
RARE Ultragenyx Pharmaceuticals 0.1%
Value $11.93M Shares 123,894 Est. Cost $51.09 Unrealized +124.1%
Threshold Pharmaceuticals, Inc. 0.1%
Value $11.91M Shares 2,925,519 Est. Cost $4.38 Unrealized
La Jolla Pharmaceutical Company 0.1%
Value $11.45M Shares 412,008 Est. Cost $10.24 Unrealized
XNCR Xencor, Inc. 0.1%
Value $10.66M Shares 872,072 Est. Cost $11.07 Unrealized +76.9%
Lion Biotechnologies, Inc. 0.1%
Value $10.47M Shares 1,817,429 Est. Cost $11.31 Unrealized
Alcobra Ltd. 0.1%
Value $9.905M Shares 1,639,871 Est. Cost $5.32 Unrealized
Akari Therapeutics PLC ADR 0.1%
Value $9.499M Shares 395,882 Est. Cost $23.99 Unrealized
Concert Pharmaceuticals, Inc. 0.1%
Value $9.308M Shares 495,908 Est. Cost $10.71 Unrealized
Osiris Therapeutics, Inc. 0.1%
Value $9.22M Shares 499,193 Est. Cost $16.34 Unrealized
Global Blood Therapeutics, Inc. 0.1%
Value $8.432M Shares 200,000 Est. Cost $42.16 Unrealized
ASND Ascendis Pharma A/S 0.1%
Value $7.709M Shares 435,540 Est. Cost $17.62 Unrealized
MGNX MacroGenics, Inc. 0.1%
Value $7.449M Shares 347,776 Est. Cost $23.68 Unrealized +32.5%
AGIO Agios Pharmaceuticals, Inc. 0.1%
Value $7.059M Shares 100,000 Est. Cost $27.47 Unrealized +255.8%
Dermira, Inc. 0.1%
Value $6.419M Shares 275,000 Est. Cost $21.44 Unrealized
Aimmune Therapeutics, Inc. 0.1%
Value $6.33M Shares 250,000 Est. Cost $25.32 Unrealized
NeuroDerm Ltd. 0.1%
Value $6.304M Shares 305,000 Est. Cost $15.24 Unrealized
LGND Ligand Pharmaceuticals Incorporated 0.1%
Value $6.286M Shares 73,386 Est. Cost $41.68 Unrealized +45.6%
Endocyte, Inc. 0.1%
Value $6.213M Shares 1,356,552 Est. Cost $4.58 Unrealized
Arrowhead Research Corp. 0.1%
Value $5.815M Shares 1,009,509 Est. Cost $9.76 Unrealized
Aerie Pharmaceuticals, Inc. 0.0%
Value $5.311M Shares 299,356 Est. Cost $17.96 Unrealized
Ignyta, Inc. 0.0%
Value $5.013M Shares 571,000 Est. Cost $8.30 Unrealized
Trevena, Inc. 0.0%
Value $4.658M Shares 450,000 Est. Cost $10.35 Unrealized
Sage Therapeutics, Inc. 0.0%
Value $4.444M Shares 105,000 Est. Cost $43.36 Unrealized
Chimerix, Inc. 0.0%
Value $4.401M Shares 115,216 Est. Cost $40.26 Unrealized
Amarin Corporation plc 0.0%
Value $4.257M Shares 2,205,710 Est. Cost $2.34 Unrealized
Pronai Therapeutics, Inc. 0.0%
Value $4.104M Shares 200,000 Est. Cost $20.52 Unrealized
Curis, Inc. 0.0%
Value $4.039M Shares 1,999,303 Est. Cost $2.72 Unrealized
Proteon Therapeutics, Inc. 0.0%
Value $3.82M Shares 274,617 Est. Cost $11.75 Unrealized
Seres Therapeutics, Inc. 0.0%
Value $3.705M Shares 125,000 Est. Cost $41.50 Unrealized
OMER Omeros Corporation 0.0%
Value $3.685M Shares 336,226 Est. Cost $12.37 Unrealized +25.9%
Nabriva Therapeutics AG 0.0%
Value $3.325M Shares 350,000 Est. Cost $9.50 Unrealized
Juno Therapeutics, Inc. 0.0%
Value $3.255M Shares 80,000 Est. Cost $52.22 Unrealized
CytRx Corporation 0.0%
Value $3.128M Shares 1,319,989 Est. Cost $3.49 Unrealized
Epizyme, Inc. 0.0%
Value $2.99M Shares 232,481 Est. Cost $21.12 Unrealized
Stemline Therapeutics, Inc. 0.0%
Value $2.945M Shares 333,497 Est. Cost $23.84 Unrealized
Array BioPharma Inc. Notes 3.0% 6/1/2020 0.0%
Value $2.921M Shares 3,000,000 Est. Cost $1.25 Unrealized
Mast Therapeutics, Inc. 0.0%
Value $2.73M Shares 4,707,464 Est. Cost $0.56 Unrealized
ENTA Enanta Pharmaceuticals, Inc. 0.0%
Value $2.723M Shares 75,357 Est. Cost $19.50 Unrealized +120.2%
NTRA Natera, Inc. 0.0%
Value $2.713M Shares 250,000 Est. Cost $16.90 Unrealized 0.0%
Sunesis Pharmaceuticals, Inc. 0.0%
Value $2.592M Shares 3,200,000 Est. Cost $2.55 Unrealized
Affimed N.V. 0.0%
Value $2.468M Shares 400,000 Est. Cost $6.30 Unrealized
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 0.0%
Value $2.45M Shares 3,423,000 Est. Cost $0.76 Unrealized
Assembly Biosciences, Inc. 0.0%
Value $2.39M Shares 250,000 Est. Cost $13.24 Unrealized
Isis Pharmaceuticals, Inc. 0.0%
Value $2.31M Shares 57,140 Est. Cost $26.87 Unrealized
Karyopharm Therapeutics Inc. 0.0%
Value $2.285M Shares 216,990 Est. Cost $31.09 Unrealized
Vitae Pharmaceuticals, Inc. 0.0%
Value $2.065M Shares 187,597 Est. Cost $11.71 Unrealized
AUPH Aurinia Pharmaceuticals Inc. 0.0%
Value $1.999M Shares 711,499 Est. Cost $3.55 Unrealized -3.5%
Dynavax Technologies Corporation 0.0%
Value $1.841M Shares 75,000 Est. Cost $24.55 Unrealized
Bellerophon Therapeutics, Inc. 0.0%
Value $1.832M Shares 352,928 Est. Cost $9.18 Unrealized
Immune Design Corp. 0.0%
Value $1.817M Shares 148,937 Est. Cost $20.65 Unrealized
IRWD Ironwood Pharmaceuticals, Inc. 0.0%
Value $1.763M Shares 169,163 Est. Cost $11.63 Unrealized -19.8%
Loxo Oncology, Inc. 0.0%
Value $1.748M Shares 100,000 Est. Cost $13.13 Unrealized
MediWound Ltd. 0.0%
Value $1.717M Shares 225,000 Est. Cost $11.38 Unrealized
Marinus Pharmaceuticals, Inc. 0.0%
Value $1.668M Shares 200,000 Est. Cost $6.47 Unrealized
Palatin Technologies, Inc. 0.0%
Value $1.661M Shares 2,050,000 Est. Cost $0.73 Unrealized
Ophthotech Corporation 0.0%
Value $1.444M Shares 35,649 Est. Cost $32.35 Unrealized
CLLS Cellectis S.A. 0.0%
Value $1.318M Shares 50,000 Est. Cost $34.58 Unrealized
Tenax Therapeutics Inc. 0.0%
Value $1.26M Shares 420,000 Est. Cost $3.58 Unrealized
ADAPY Adaptimmune Therapeutics plc ADR 0.0%
Value $1.197M Shares 100,000 Est. Cost $18.33 Unrealized
BioDelivery Sciences International, Inc. 0.0%
Value $1.168M Shares 210,021 Est. Cost $5.21 Unrealized
ABUS Arbutus Biopharma Corporation 0.0%
Value $1.1M Shares 180,582 Est. Cost $8.87 Unrealized 0.0%
Discovery Laboratories, Inc. 0.0%
Value $1.071M Shares 3,569,643 Est. Cost $1.95 Unrealized
Ohr Pharmaceuticals, Inc. 0.0%
Value $1.022M Shares 370,370 Est. Cost $2.54 Unrealized
ALNY Alnylam Pharmaceuticals, Inc. 0.0%
Value $911K Shares 11,340 Est. Cost $77.42 Unrealized +43.5%
ALDX Aldeyra Therapeutics, Inc. 0.0%
Value $828K Shares 142,000 Est. Cost $10.20 Unrealized -23.5%
Trillium Therapeutics, Inc. 0.0%
Value $821K Shares 63,014 Est. Cost $13.03 Unrealized
Ritter Pharmaceuticals, Inc. 0.0%
Value $820K Shares 400,000 Est. Cost $4.45 Unrealized
Acceleron Pharma, Inc. 0.0%
Value $716K Shares 28,765 Est. Cost $39.60 Unrealized
QURE UniQure B.V. 0.0%
Value $614K Shares 30,000 Est. Cost $15.95 Unrealized +65.1%
Achaogen, Inc. 0.0%
Value $576K Shares 100,000 Est. Cost $15.46 Unrealized
Foundation Medicine, Inc. 0.0%
Value $385K Shares 20,892 Est. Cost $25.16 Unrealized
Synergy Pharmaceuticals, Inc. 0.0%
Value $356K Shares 67,100 Est. Cost $5.31 Unrealized
ChemoCentryx, Inc. 0.0%
Value $297K Shares 49,064 Est. Cost $14.14 Unrealized
Five Prime Therapeutics, Inc. 0.0%
Value $296K Shares 19,247 Est. Cost $16.80 Unrealized
Aptose Biosciences, Inc. 0.0%
Value $144K Shares 33,397 Est. Cost $5.91 Unrealized
Cyclacel Pharmaceuticals, Inc. Pfd. Conv. Ex 6% 0.0%
Value $62,000 Shares 13,253 Est. Cost $7.20 Unrealized
BioTime, Inc. Rights 0.0%
Value $17,000 Shares 20,084 Est. Cost $1.07 Unrealized